Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omacor for Endothelial Function in T2DM
NCT00328536Phase 4Completed
- Sponsor
- Ruhr University Bochum
- Start
- Apr 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omega-3-acid triglycerides in type 2 diabetes mellitus (T2DM), atherosclerosis, sponsored by Ruhr University Bochum. Started Apr 2007; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
type 2 diabetes mellitus (T2DM)atherosclerosis
Beyond the preview
Go deeper on NCT00328536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328536.